Anzeige
Mehr »
Montag, 02.03.2026 - Börsentäglich über 12.000 News
Erste Psilocybin-Behandlungen laufen - warum steht Optimi noch bei Pennystock-Level?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von MassDevice

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
19:58BD earns FDA 510(k) clearance for Surgiphor 1000mL system
18:58Boston Scientific wins expanded CE mark for Farapulse in persistent AFib
17:583 tips for medtech entrepreneurs from a venture capital pro
16:59Novocure has reimbursement win for Optune Lua in Japan
15:58RadNet acquires AI radiology tech company Gleamer for $269.3M
13:59Intuitive expands direct operations for da Vinci, Ion distro in Europe
13:59Smith+Nephew posts Q4 sales beat amid overall strategy shift
00:58How Apple Rubber's Rapid Prototyping Kept Whale Research Afloat
00:58Former Zimmer Biomet leader Kraal to head up Baxter Connected Care
FrAbbott earns FDA green light for next-gen CardioMEMS pulmonary artery pressure reader
FrThink Surgical announces first TMINI robot cases with Stryker knee implant
FrSynergy Spine gets FDA nod for cervical disc
FrBlueWind Medical data backs Revi tibial neuromod for UUI
FrBoston Scientific enters into multiple credit facilities totaling $11B
FrDexcom adds Google exec to its board
FrSolventum exceeds earnings estimates in first year as solo company
DoGE HealthCare inks 10-year Care Alliance with UCSF Health
DoHighridge Medical begins limited rollout of activL lumbar disc
DoEdwards advances global heart health initiatives
DoBlue Arbor adds $5M in Ottobock partnership to advance neuromuscular interface
DoJohnson & Johnson Medtech launches new CereGlide aspiration catheters in US
DoMedtronic reports positive findings for Altaviva tibial neuromod for urinary incontinence
DoEnovis posts 24% sales growth in mixed Q4
MiTrinity Biotech raises $25M as it looks to advance CGM+ system
MiBoston Scientific promotes new president of Vascular Therapies from within